Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6318474

CC(=O)NCc1ccc(N/C(=C2\C(=O)Nc3ccc([N+](=O)[O-])cc32)c2ccc(CNC(C)=O)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 4/20 0.42
PDPK1 O15530 2/20 0.42
EGFR P00533 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CAPN9 O14815 1/20 0.38
CASP3 P42574 1/20 0.38
ALDH1A1 P00352 3/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
MPI P34949 1/20 0.37
BLM P54132 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GSK3B P49841 2/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAOA P21397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6320223 0.96 AKT2 (0.41) AKT2PDPK1EGFRCA12CA1
Trifluoroacetic Acid SCHEMBL6322940 0.95 AKT2 (0.41) AKT2PDPK1EGFRCA12CA1
SCHEMBL6328248 0.91 PDPK1 (0.45) AKT2PDPK1EGFRCA12CA1
SCHEMBL6328256 0.91 PDPK1 (0.45) AKT2PDPK1EGFRCA12CA1
SCHEMBL6317484 0.90 AKT2 (0.45) AKT2PDPK1EGFRCA12CA1
SCHEMBL6319717 0.90 AKT2 (0.45) AKT2PDPK1EGFRCA12CA1
SCHEMBL6321689 0.88 PDPK1 (0.41) AKT2PDPK1EGFRCA12CA1
SCHEMBL8012194 0.85 SMN1; SMN2 (0.42) AKT2PDPK1EGFRCA12CA1
SCHEMBL8012200 0.85 SMN1; SMN2 (0.42) AKT2PDPK1EGFRCA12CA1
SCHEMBL6319988 0.84 PDPK1 (0.38) AKT2PDPK1EGFRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 EP disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 WO disclosed
EP-1115704-B1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-06-18 EP disclosed